We then investigated the effect of rGDF11 on angiogenesis at 14 days after stroke and found that rGDF11-treated mice showed a significant increase in CD31-positive microvascular length and area and the number of vascular branches. The gene discussed is PECAM1; the disease is stroke disorder.